Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
or

Zoetis Inc Cl A (ZTS)

Zoetis Inc Cl A (ZTS)
146.00 x 1 152.00 x 17
Post-market by (Cboe BZX)
146.85 -1.32 (-0.89%) 04/21/25 [NYSE]
146.00 x 1 152.00 x 17
Post-market 147.56 +0.71 (+0.48%) 16:47 ET
Quote Overview for Mon, Apr 21st, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
145.30
Day High
148.67
Open 148.67
Previous Close 148.17 148.17
Volume 2,654,933 2,654,933
Avg Vol 2,884,352 2,884,352
Stochastic %K 31.39% 31.39%
Weighted Alpha -15.16 -15.16
5-Day Change -2.59 (-1.73%) -2.59 (-1.73%)
52-Week Range 139.70 - 200.33 139.70 - 200.33
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 66,333,580
  • Shares Outstanding, K 446,180
  • Annual Sales, $ 9,256 M
  • Annual Income, $ 2,486 M
  • EBIT $ 3,274 M
  • EBITDA $ 3,771 M
  • 60-Month Beta 0.92
  • Price/Sales 7.07
  • Price/Cash Flow 20.76
  • Price/Book 13.88

Options Overview Details

View History
  • Implied Volatility 41.02% ( +4.14%)
  • Historical Volatility 34.89%
  • IV Percentile 97%
  • IV Rank 79.37%
  • IV High 46.55% on 04/07/25
  • IV Low 19.76% on 08/16/24
  • Put/Call Vol Ratio 0.60
  • Today's Volume 1,663
  • Volume Avg (30-Day) 2,024
  • Put/Call OI Ratio 0.51
  • Today's Open Interest 24,643
  • Open Int (30-Day) 38,814

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 1.40
  • Number of Estimates 10
  • High Estimate 1.44
  • Low Estimate 1.37
  • Prior Year 1.38
  • Growth Rate Est. (year over year) +1.45%

Price Performance

See More
Period Period Low Period High Performance
1-Month
139.70 +5.12%
on 04/09/25
Period Open: 163.03
166.34 -11.72%
on 04/03/25
-16.18 (-9.92%)
since 03/21/25
3-Month
139.70 +5.12%
on 04/09/25
Period Open: 167.53
177.40 -17.22%
on 02/06/25
-20.68 (-12.34%)
since 01/21/25
52-Week
139.70 +5.12%
on 04/09/25
Period Open: 146.50
200.33 -26.70%
on 09/19/24
+0.35 (+0.24%)
since 04/19/24

Most Recent Stories

More News
A Once-in-a-Decade Opportunity: 3 Magnificent Stocks Down Between 40% and 73% to Buy Right Now

The S&P 500 has dropped 10% or more nine times since 2010, not including the current sell-off. However, the index has delivered an average return of 18% in the year following the start date of these corrections...

WING : 210.82 (-3.66%)
ZTS : 146.85 (-1.22%)
YETI : 27.49 (-1.33%)
PFE : 22.04 (-0.45%)
3 Magnificent Stocks to Buy That Are Near 52-Week Lows

It's been a tough start to 2025 for investors amid concerns regarding the strength of the U.S. economy and uncertainties over the effect of sweeping changes in trade policy under the Trump administration....

ZTS : 146.85 (-1.22%)
NKE : 56.12 (+0.65%)
PFE : 22.04 (-0.45%)
2 of Wall Street’s Favorite Stocks with Competitive Advantages and 1 to Be Wary Of

2 of Wall Street’s Favorite Stocks with Competitive Advantages and 1 to Be Wary Of

ZTS : 146.85 (-1.22%)
HOOD : 39.85 (-3.23%)
DHR : 184.96 (-1.00%)
Q4 Earnings Highs And Lows: Eli Lilly (NYSE:LLY) Vs The Rest Of The Branded Pharmaceuticals Stocks

Q4 Earnings Highs And Lows: Eli Lilly (NYSE:LLY) Vs The Rest Of The Branded Pharmaceuticals Stocks

CORT : 62.90 (+1.06%)
SUPN : 30.29 (-1.53%)
LLY : 818.02 (-2.61%)
ZTS : 146.85 (-1.22%)
BMY : 48.94 (-0.59%)
Q4 Earnings Roundup: Organon (NYSE:OGN) And The Rest Of The Branded Pharmaceuticals Segment

Q4 Earnings Roundup: Organon (NYSE:OGN) And The Rest Of The Branded Pharmaceuticals Segment

CORT : 62.90 (+1.06%)
OGN : 10.63 (-4.41%)
SUPN : 30.29 (-1.53%)
MRK : 77.85 (-0.19%)
ZTS : 146.85 (-1.22%)
This Magnificent Dividend Stock Has Increased Its Payouts by 500% in 10 Years

There are many dividend stocks on equity markets, but not all are attractive to income investors. Those that go beyond paying a quarterly payout but also consistently raise their dividends -- all while...

ZTS : 146.85 (-1.22%)
A Look Back at Branded Pharmaceuticals Stocks’ Q4 Earnings: Collegium Pharmaceutical (NASDAQ:COLL) Vs The Rest Of The Pack

A Look Back at Branded Pharmaceuticals Stocks’ Q4 Earnings: Collegium Pharmaceutical (NASDAQ:COLL) Vs The Rest Of The Pack

RPRX : 32.19 (-1.26%)
COLL : 26.91 (-0.37%)
SUPN : 30.29 (-1.53%)
OGN : 10.63 (-4.41%)
ZTS : 146.85 (-1.22%)
Zoetis' Stock Is About as Cheap as It's Ever Been. 1 Thing to Know Before You Buy.

Shares in animal pharmaceutical company Zoetis (NYSE: ZTS) have been under a cloud since the release of the company's fourth-quarter earnings report in mid-February. The Q4 numbers were fine, but the company's...

JPM : 228.99 (-1.28%)
ZTS : 146.85 (-1.22%)
Unpacking Q4 Earnings: Pfizer (NYSE:PFE) In The Context Of Other Branded Pharmaceuticals Stocks

Unpacking Q4 Earnings: Pfizer (NYSE:PFE) In The Context Of Other Branded Pharmaceuticals Stocks

SUPN : 30.29 (-1.53%)
OGN : 10.63 (-4.41%)
ZTS : 146.85 (-1.22%)
PFE : 22.04 (-0.45%)
BMY : 48.94 (-0.59%)
Q4 Earnings Highs And Lows: Royalty Pharma (NASDAQ:RPRX) Vs The Rest Of The Branded Pharmaceuticals Stocks

Q4 Earnings Highs And Lows: Royalty Pharma (NASDAQ:RPRX) Vs The Rest Of The Branded Pharmaceuticals Stocks

RPRX : 32.19 (-1.26%)
COLL : 26.91 (-0.37%)
SUPN : 30.29 (-1.53%)
OGN : 10.63 (-4.41%)
ZTS : 146.85 (-1.22%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Zoetis Inc. is a leader in the animal health space with a focus on both livestock and companion animals in seven major product categories: vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. Zoetis has a diversified...

See More

Key Turning Points

3rd Resistance Point 151.95
2nd Resistance Point 150.31
1st Resistance Point 148.58
Last Price 146.85
1st Support Level 145.21
2nd Support Level 143.57
3rd Support Level 141.84

See More

52-Week High 200.33
Fibonacci 61.8% 177.17
Fibonacci 50% 170.01
Fibonacci 38.2% 162.86
Last Price 146.85
52-Week Low 139.70

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro